These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 7496197)

  • 21. The phenomenon of treatment failures in Human African Trypanosomiasis.
    Brun R; Schumacher R; Schmid C; Kunz C; Burri C
    Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapses following treatment of early-stage Trypanosoma brucei gambiense sleeping sickness with a combination of pentamidine and suramin.
    Pépin J; Khonde N
    Trans R Soc Trop Med Hyg; 1996; 90(2):183-6. PubMed ID: 8761585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis.
    Doua F; Miezan TW; Sanon Singaro JR; Boa Yapo F; Baltz T
    Am J Trop Med Hyg; 1996 Dec; 55(6):586-8. PubMed ID: 9025682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of human African trypanosomiasis--present situation and needs for research and development.
    Legros D; Ollivier G; Gastellu-Etchegorry M; Paquet C; Burri C; Jannin J; Büscher P
    Lancet Infect Dis; 2002 Jul; 2(7):437-40. PubMed ID: 12127356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
    Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
    Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story.
    Baker N; de Koning HP; Mäser P; Horn D
    Trends Parasitol; 2013 Mar; 29(3):110-8. PubMed ID: 23375541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in sleeping sickness therapy.
    Van Nieuwenhove S
    Ann Soc Belg Med Trop; 1992; 72 Suppl 1():39-51. PubMed ID: 1417168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Agents for the treatment of African sleeping sickness. Those developed in the last century].
    Schlitzer M
    Pharm Unserer Zeit; 2009; 38(6):552-8. PubMed ID: 19862727
    [No Abstract]   [Full Text] [Related]  

  • 29. An alternative form of melarsoprol in sleeping sickness.
    Kennedy PG
    Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metronidazole and suramin combination in the treatment of arsenical refractory Rhodesian sleeping sickness--a case study.
    Foulkes JR
    Trans R Soc Trop Med Hyg; 1996; 90(4):422. PubMed ID: 8882195
    [No Abstract]   [Full Text] [Related]  

  • 31. Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the Republic of the Congo.
    Balasegaram M; Harris S; Checchi F; Ghorashian S; Hamel C; Karunakara U
    Bull World Health Organ; 2006 Oct; 84(10):783-91. PubMed ID: 17128358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
    Chappuis F
    Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
    [No Abstract]   [Full Text] [Related]  

  • 33. African sleeping sickness.
    Hedley L; Fink D; Sparkes D; Chiodini PL
    Br J Hosp Med (Lond); 2016 Oct; 77(10):C157-C160. PubMed ID: 27723399
    [No Abstract]   [Full Text] [Related]  

  • 34. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
    Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
    Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The return of sleeping sickness in an epidemic form: international action for drugs].
    Kager PA
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2527-30. PubMed ID: 12532663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
    Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human African trypanosomiasis: potential therapeutic benefits of an alternative suramin and melarsoprol regimen.
    Jennings FW; Rodgers J; Bradley B; Gettinby G; Kennedy PG; Murray M
    Parasitol Int; 2002 Dec; 51(4):381-8. PubMed ID: 12421636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug resistance in human African trypanosomiasis.
    Barrett MP; Vincent IM; Burchmore RJ; Kazibwe AJ; Matovu E
    Future Microbiol; 2011 Sep; 6(9):1037-47. PubMed ID: 21958143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
    Eperon G; Schmid C; Loutan L; Chappuis F
    Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.